XVAs boost Helaba trading income but inflate hedging costs

Expense from non-trading hedges reaches highest since at least 2016

Derivatives valuation adjustments (XVAs) cut both ways at German lender Helaba in the first half of the year, propelling trading income to the highest in at least six years while pushing hedging costs to their highest since the beginning of the Covid-19 pandemic.

Trading income hit €299 million ($299 million) in the six months to end-June – reversing a €28 million loss in H2 2021 and more than tripling from H1 2021 – with the bank citing, among other factors, “a marked change in [XVAs] that

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

If you already have an account, please sign in here.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: